
GSK2018682
CAS No. 1034688-30-6
GSK2018682( —— )
Catalog No. M20904 CAS No. 1034688-30-6
GSK2018682 is an agonist of sphingosine-1-phosphate receptor ?(s1p1) and (s1p5) agonist(pEC50s of 7.7 and 7.2respectively).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 27 | In Stock |
![]() ![]() |
5MG | 42 | In Stock |
![]() ![]() |
10MG | 72 | In Stock |
![]() ![]() |
25MG | 140 | In Stock |
![]() ![]() |
50MG | 260 | In Stock |
![]() ![]() |
100MG | 385 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGSK2018682
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK2018682 is an agonist of sphingosine-1-phosphate receptor ?(s1p1) and (s1p5) agonist(pEC50s of 7.7 and 7.2respectively).
-
DescriptionGSK2018682 is an agonist of sphingosine-1-phosphate receptor ?(s1p1) and (s1p5) agonist(pEC50s of 7.7 and 7.2respectively).(In Vitro):GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4.
-
In VitroGSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetS1P Receptor
-
RecptorS1P
-
Research AreaOthers
-
IndicationMultiple sclerosis
Chemical Information
-
CAS Number1034688-30-6
-
Formula Weight440.88
-
Molecular FormulaC22H21ClN4O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (283.52 mM)
-
SMILESCC(C)Oc1ncc(-c2nc(-c3cccc4c3ccn4CCCC(=O)O)no2)cc1Cl
-
Chemical Name4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-124-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xu J Gray F Henderson A et al. Safety pharmacokinetics pharmacodynamics and bioavailability of GSK2018682 a sphingosine-1-phosphate receptor modulator in healthy volunteers[J]. Clinical Pharmacology in Drug Development 2014 3(3):170-178.
molnova catalog



related products
-
PF-543 hydrochloride
PF-543 inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.
-
SKI V
SKI V is a potent and noncompetitive non-lipid sphingosine kinase (SPHK; SK) inhibitor (GST-hSK,IC50 : 2 μM), and is a PI3K inhibitor(hPI3k,IC50 : 6 μM), induces apoptosis and has antitumor activity
-
BMS-960
BMS-960 is an S1P agonist with potential anti-tumour activity for cancer research.